Drug-Coated Balloon Catheter Market Size to Reach USD 2.41 Billion by 2034 at a 8.28% CAGR from 2026 to 2034
The drug-coated balloon catheter market size was valued at USD 1.18 billion in 2025 and is expected to reach USD 2.41 billion by 2034, growing at a CAGR of 8.28%. Drug-coated balloon catheters are medical devices used to treat blocked and narrowed blood vessels across various cardiovascular procedures. They help to improve blood flow, reduce restenosis risk, minimize repeat interventions, and deal with other treatment challenges.
Key Statistics:
- Market Size (2025): USD 1.18Billion
- Market Size (2034): USD 2.41 Billion
- CAGR (2026-2034): 8.28%
- Dominating Region: North America
Report Highlights:
- Rising cardiovascular disease is increasing demand for drug-coated balloon catheter.
- Growing adoption of minimally invasive procedure is driving the growth of drug-coated balloon catheter market.
- High device cost is creating market challenges.
- Expansion in emerging markets to open opportunities for the market.
- Coronary DCB dominated the market in 20205, due to the increasing prevalence of coronary artery disease and rising adoption of minimally invasive cardiac procedures.
- North America led the market driven by the high prevalence of cardiovascular diseases and strong adoption of minimally invasive vascular procedures.
- Key companies include Boston Scientific Corporation, Medtronic plc, B. Braun SE, Concept Medical Inc., Abbott, and others.
What’s Included in Drug-Coated Balloon Catheter Report?
The report presents a detailed overview of the market for drug-coated balloon catheter based on product type, application, and end-use industry. It includes regional analysis, value chain assessment, and competitive landscape.
What are Driving Factors and Emerging Trends of Drug-Coated Balloon Catheter Market?
As per our analysis, the market is increasing due to rising cardiovascular disease and growing adoption of minimally invasive procedure. The major factors that are responsible for the growth of the drug-coated balloon catheter market are:
- Rising Cardiovascular Disease: Rising cardiovascular disease cases has led to higher demand for minimally invasive vascular treatments across hospitals and cardiac care centers. The US Centers for Disease Control and Prevention stated that about 805,000 people in the US have a heart attack annually, including 605,000 first-time heart attacks, and 200,000 recurrent cases.
- Growing Adoption of Minimally Invasive Procedure: The growing preference for minimally invasive cardiovascular treatments is resulting in the higher use of angioplasty procedures across hospitals and cardiac care centers. The National Library of Medicine, minimally invasive cardiac surgery accounts for one-third of total heart surgeries globally that is performed for mitral valve repair, aortic valve replacement, and coronary artery bypass.
- Expansion in Emerging Markets: Rising healthcare investments and expansion of cardiovascular care facilities in developing countries are supporting market growth.
These factors indicate increasing demand for minimally invasive, high-performance, and technologically advanced drug-coated balloon catheters for improving treatment efficiency, reducing restenosis risk, and enhancing patient outcomes.
Request a free sample copy or read the full market insights: Drug Coated Ballon Catheter Market Report
Which Key Segments are Driving Drug-Coated Balloon Catheter Market?
By Product Type Analysis
Coronary DCB segment held the largest market share driven by the increasing prevalence of coronary artery disease and rising adoption of minimally invasive cardiac procedures.
By Application Analysis
Coronary artery disease dominated the market due to the increasing burden of cardiovascular diseases and growing number of angioplasty procedures worldwide.
By End-Use Industry Analysis
Hospitals dominated the market driven by the high volume of cardiovascular and vascular intervention procedures performed in hospital settings.
Which is Dominating Region in Drug-Coated Balloon Catheter Market?
North America: North America dominated in 2025 driven by the high prevalence of cardiovascular diseases and strong adoption of minimally invasive vascular procedures. The US Centers for Disease Control and Prevention reported that 919,032 people died from cardiovascular disease in the US in 2023, showing huge demand for DCB catheters.
Asia Pacific: Asia Pacific is expected to grow at the fastest rate due to the growing burden of cardiovascular disorders and expanding healthcare infrastructure.
Where is Drug-Coated Balloon Catheter Market Headed?
According to analysis, the market is moving toward steady expansion supported by expansion in emerging markets and technological advancements in DCB catheter.
What Drug-Coated Balloon Catheter Market Report Reveals?
- What is the global market size, growth trend, and CAGR for drug-coated balloon catheter through 2034?
- What are the factors driving the market growth?
- Who are the top companies, and what is their relative position in terms of competitive positioning?
- How are providers advancing technologies to improve catheter quality?
- How are the technological advancements in DCB catheter shaping the drug-coated balloon catheter market?
- What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- Where do new opportunities arise in the drug-coated balloon catheter market?
Who are Major Drug-Coated Balloon Catheter Market Contributors?
According to our study, a few firms are leading in the global market. The following are some of the major market contributors:
- Boston Scientific Corporation
- Medtronic plc
- B. Braun SE
- Concept Medical Inc.
- Abbott
- Koninklijke Philips N.V.
- Teleflex Incorporated
- MicroPort Scientific Corporation
- iVascular S.L.U.
- Meril Life Sciences Pvt. Ltd.
- Cordis
- Translumina Therapeutics
Market Segments Covered
By Product Type Outlook (Revenue, USD Billion, 2021-2034)
- Coronary DCB
- Peripheral DCB
By Application Outlook (Revenue, USD Billion, 2021-2034)
- Coronary Artery Disease
- Peripheral Artery Disease
- Renal Artery Disease
- Biliary Tract
By End-Use Industry Outlook (Revenue, USD Billion, 2021-2034)
- Hospitals
- Specialty Cardiac Centers
- Ambulatory Surgical Centers
By Regional Outlook (Revenue, USD Billion, 2021-2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
